Neudata research | PurpleLab

PurpleLab

Visit website

Request a demo Claim this profile

PurpleLab is attending the

[]

About PurpleLab

DDQ available

PurpleLab is a healthcare data and analytics provider. The firm structurally and semantically harmonizes disparate healthcare datasets, including provider profiles, medical and pharmacy claims, and medical terminology reference data.

PurpleLab's HealthNexus platform enables a hosted SaaS ecosystem that sits on top of the Life Science Industry's most comprehensive longitudinal patient insights network allowing early insights into patient care, industry trends and detailed understanding of evolving treatment dynamics.

PurpleLab products

On chain data

New today

Request information

[{"title":"Healthcare provider profiles","url":"https://neudata.co/datasets/healthcare-provider-profiles-1","publication_flag":null},{"title":"US open and closed claims","url":"https://neudata.co/datasets/us-open-and-closed-claims","publication_flag":null}]

Similar vendors to PurpleLab

Neudata has identified 16 vendors that have similar offerings to PurpleLab. Request the full report to find out more.

Advanced Technologies

Quality Assurance

Essential Supplies

NextGen Services

Innovative Strategies

Synergy Partners

Pioneer Solutions

Urban Developments

Noble Ventures

Visionary Concepts

Elite Marketing

Prime Consulting

Future Tech

Bright Ideas

Dynamic Systems

Global Services

Creative Designs

Smart Logistics

Green Innovations

Tech Solutions

News and intelligence related to PurpleLab

[{"title":"Healthcare claims disruptions: What next?","image":"https://neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBZ0ZSIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--840394b34a095a942ee137215240a49643591845/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZzBNREFHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--7ae9fca008c09185b871bf2fe86c179a519caa00/towfiqu-barbhuiya-w8p9cQDLX7I-unsplash.jpg","url":"https://neudata.co/intelligence/healthcare-claims-disruptions-what-next","publication_date":"2024-06-18","category":"Intelligence"},{"title":"Deal or no deal: Using deal-sourcing datasets for private equity","image":"https://neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdDVOIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--977fc217e566c83f64dd609ab5d7f0f4a13a3e33/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZzBNREFHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--7ae9fca008c09185b871bf2fe86c179a519caa00/anthony-tyrrell-Bl-LiSJOnlY-unsplash.jpg","url":"https://neudata.co/intelligence/deal-or-no-deal-using-deal-sourcing-datasets-for-private-equity","publication_date":"2024-03-27","category":"Intelligence"},{"title":"Money meets medicine: The private equity prescription for alternative healthcare data","image":"https://neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBc2hLIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--6f0e79dbaa8e95280adccac08cdfa20b2efcf885/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZzBNREFHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--7ae9fca008c09185b871bf2fe86c179a519caa00/christine-sandu-jwWtZrm67VI-unsplash.jpg","url":"https://neudata.co/intelligence/money-meets-medicine-the-private-equity-prescription-for-alternative-healthcare-data","publication_date":"2024-01-10","category":"Intelligence"},{"title":"Healthcare revisited – A quick 2023 bird’s-eye view","image":"https://neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBc3BLIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--2546ed8339bb6683b746f3e0adc4cec181a8ea4e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZ3pNVEVHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--b55e821fff1fb6a5277a641f9807539f25cc39cc/christina-victoria-craft-ZHys6xN7sUE-unsplash.jpg","url":"https://neudata.co/intelligence/healthcare-revisited-a-quick-2023-birds-eye-view","publication_date":"2023-09-27","category":"Intelligence"},{"title":"Who were the most popular vendors at Neudata’s NYC Data Insights & Scouting Summit — March 2022","image":"https://neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBazlJIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--5225981c2959445d82c9eb179d03efea45c73447/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZ3pNVEVHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--b55e821fff1fb6a5277a641f9807539f25cc39cc/bruno-nascimento-9XTyIiFceKM-unsplash.jpg","url":"https://neudata.co/alternative-data-news/who-were-the-most-popular-vendors-at-neudatas-nyc-data-insights-scouting-summit-march-2022","publication_date":"2022-04-05","category":"News"},{"title":"Alternative Data for Healthcare Investors (Part IV): Claims vs EHRs","image":"https://neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBc2RLIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--1a900f49c1104888b3f6d591f057f0b4893191cf/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZzBNREFHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--7ae9fca008c09185b871bf2fe86c179a519caa00/part-iv-HEADER.jpg","url":"https://neudata.co/intelligence/alternative-data-for-healthcare-investors-part-iv-claims-vs-ehrs","publication_date":"2019-09-12","category":"Intelligence"},{"title":"Alternative Data for Healthcare Investors (Part I): A Primer on Real-World Data","image":"https://neudata.co/rails/active_storage/representations/proxy/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBckpMIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--ee0bcefbb716c95505b7a0536284a57952d7e181/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJY0c1bkJqb0dSVlE2QzNKbGMybDZaVWtpRERZd01IZzBNREFHT3daVSIsImV4cCI6bnVsbCwicHVyIjoidmFyaWF0aW9uIn19--7ae9fca008c09185b871bf2fe86c179a519caa00/header-option-1-aerial-view-application-935869-1.jpg","url":"https://neudata.co/intelligence/alternative-data-for-healthcare-investors-part-i-a-primer-on-real-world-data","publication_date":"2019-03-14","category":"Intelligence"}]

PurpleLab risk check

Dataset type(s) - select all that apply.

Please highlight any of the following components that may be included in your categories selected above (Personal data, location data, demographic data, or other sensitive data elements).

Please list the data products this assessment covers.

Mauris eu cursus odio, sit amet aliquam sem.

How long have you been selling data?

Donec tempor, libero non ultrices volutpat.

Please highlight any relevant litigation or negative press.

Phasellus dolor tellus.

How many financial services firms are using your data (excluding corporate users and unpaid trialists)?

Cras mattis, turpis sit amet volutpat viverra.

Request access

[]

About Neudata

Neudata provides unbiased research and expert consultancy on data sources and use cases. We connect data buyers and sellers through our platform, creating efficiencies for people who work with data.

Our platform includes in-depth research on thousands of data vendors, which are evaluated on over 100 unique factors to ensure their usability for data buyers.

Data buyers: Discover, manage, stay ahead

We exist to simplify the complex world of data discovery. By guiding investment teams through sourcing, trialling and managing data, we empower them to focus on what they do best – generating alpha.

Let's get started

Are you PurpleLab?

Take control of your Neudata profile to ensure accurate representation of your data offerings and maximise visibility with qualified buyers in the investment space.

Claim your profile

Request a full version of this report

Neudata publishes in-depth research on data vendor products and offerings, including information on pricing and the competitive landscape. Fill out your details below to request a full version of this research report.

Founded

2016

Company history

Office locations

Wayne, PA

Number of employees

55+

Sources of funding

PurpleLab raised $3m in growth financing from Edison Partners in August 2019 Series B $40m Sep 2022

Contact name

John Smith

Contact role

Analyst